Cardiac Resynchronization Therapy Optimization
|
May 08, 2009
|
International
|
Electrophysiology
|
CRT Systems : CRTs
One-third of patients with low ejection fraction (EF) and class III to IV heart failure exhibit wide QRS duration. Wide QRS duration is associated with ventricular dyssynchrony which, in turn, can manifest in:
- Suboptimal ventricular filling
- Reduction in left ventricular dP/dt (rate of rise of ventricular contractile force or pressure)
- Prolonged duration and severity of mitral regurgitation
- Paradoxical septal wall motion.1
Cardiac resynchronization therapy (CRT) is designed to improve myocardial performance by electrically activating the right and left sides of the heart to optimize atrioventricular, intraventricular and interventricular synchronization. To optimize CRT and enhance clinical outcomes, studies recommend:
- Selecting the shortest possible A-V delay which allows complete ventricular filling, thereby optimizing stroke volume and minimizing pre-systolic mitral regurgitation.2
- Optimizing VV timing. 3,4,5
However, CRT programming can be challenging:
- Optimal AV delays vary between patients6 and optimal AV and VV delays for individual patients change over time necessitating individualized and ongoing optimization7.

- Traditional echo-based methods of optimization require a skilled echo sonographer and coordination of clinical services which creates time, cost and other resource constraints
In one simple step, QuickOptTM Timing Cycle Optimization helps clinicians quickly achieve optimal hemodynamic performance for their patients through individually tailored AV delays. Using IEGM-based optimization, QuickOpt Optimization characterizes interatrial conduction patterns in order to maximize preload and allow proper timing of mitral valve closure. QuickOpt Timing Cycle Optimization provides a clinically proven 97% correlation to echocardiography, providing the opportunity for optimization of AV delay in about a minute at every visit.8
Porciani, et al., used real-time 3D echocardiography to assess the clinical effects of QuickOpt Timing Cycle Optimization on LV asynchrony and performance. During patient follow-up (9 +/- 8 months post-implant) echocardiography was performed before and after QuickOpt optimization of AV and VV delays. The study found significant improvements in cardiac function.9
Baker, et al, compared IEGM methods and echocardiogram for optimization of AV and VV delay in heart failure patients. IEGM was found to provide a reliable, clinically correlated alternative to echo-based optimization techniques.10
Related Topics of Interest
Request More Information
Complete the form below to have a St. Jude Medical sales representative contact you. * Indicates a required field.